Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rare cancers, Rare and paediatric cancers without markets, IMRT / IGRT (modern external beam), Sarcomas (soft tissue, bone, GIST) and the tags rare, sarcoma, paediatric.
Shares Rare cancers, Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST) and the tags rare, sarcoma, paediatric.
Shares MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma, Rare cancers, Rare and paediatric cancers without markets, Doxorubicin and the tags rare, sarcoma.
Shares MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma, PI3K / AKT / mTOR, Vincristine, Doxorubicin and the tags sarcoma, paediatric.
Shares Rare cancers, Active surveillance, Rare and paediatric cancers without markets, Doxorubicin and the tags rare, sarcoma.
Shares MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma, French Sarcoma Group, Pazopanib, Leiomyosarcoma and the tags rare, sarcoma.
Shares Rare cancers, Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST) and the tags rare, sarcoma.
Shares Rare cancers, Rare and paediatric cancers without markets, IMRT / IGRT (modern external beam), Cytotoxic chemotherapy and the tags rare, paediatric.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.